Pretreatment of anti-RAGE antibody substantially decreased TGF-β1 and p-smad2/3 expression of cardiac fibroblasts, suggesting the presence of RAGE/TGF-β signaling pathway in heart failure (146). This evidence concerns the gene TGFB1 and heart failure.